menu
    • menu

    Company profile for Jaguar Health

    NEW Drugs in Dev: 3
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is appr...
    Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jaguar HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Mission Street, Suite 2375, San Francisco, CA 94105, US
    Telephone
    Telephone
    (415) 371-8300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jaguar.health/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jaguar-health/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Regains Nasdaq Compliance, Gets Bid Price Extension
    Jaguar Health Regains Nasdaq Compliance, Gets Bid Price Extension

    08 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-08/jaguar-health-regains-compliance-with-nasdaqs-publicly-held-shares-requirement-and-receives-additio

    PHARMIWEB
    08 May 2026
    Share Share
    Jaguar Health Launches Neonorm Dog for Companion Animal Gut
    Jaguar Health Launches Neonorm Dog for Companion Animal Gut

    04 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-04/jaguar-health-expands-neonorm-franchise-with-introduction-of-neonorm-dog-for-companion-animal-gut-he

    PHARMIWEB
    04 May 2026
    Share Share
    Jaguar Health Announces Statistically Significant Results
    Jaguar Health Announces Statistically Significant Results

    29 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-29/jaguar-health-announces-statistically-significant-results-from-effectiveness-trial-of-crofelemer-fd

    PHARMIWEB
    29 Apr 2026
    Share Share
    Jaguar Health Announces Reverse Stock Split for Nasdaq Compliance
    Jaguar Health Announces Reverse Stock Split for Nasdaq Compliance

    27 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-27/jaguar-health-granted-extension-until-may-15-2026-to-demonstrate-compliance-with-nasdaqs-bid-pric

    PHARMIWEB
    27 Apr 2026
    Share Share
    Jaguar Health Reports Full Approval at April 2026 Meeting
    Jaguar Health Reports Full Approval at April 2026 Meeting

    20 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-20/jaguar-health-reports-approval-of-all-proposals-at-april-2026-special-meeting-of-stockholders

    PHARMIWEB
    20 Apr 2026
    Share Share
    AI Boosts Jaguar Health's Crofelemer for Rare Disease Therapy
    AI Boosts Jaguar Health's Crofelemer for Rare Disease Therapy

    13 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-13/artificial-intelligence-ai-platforms-could-enhance-jaguar-healths-development-and-anticipated-com

    PHARMIWEB
    13 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search